OTCMKTS:ANTB

(ANTB) (ANTB) Stock Price, News & Analysis

Notice: This company has been marked as potentially delisted and may not be actively trading.
Today's Range
$0.81
$0.83
50-Day Range
N/A
52-Week Range
$0.75
$1.25
Volume
2,100 shs
Average Volume
8,783 shs
Market Capitalization
N/A
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
N/A

About (ANTB)

Rezolute, Inc. is biopharmaceutical company, which engages in the development of drug therapies for patients with metabolic and orphan diseases. Its products portfolio include RZ358-Phase 2, an antibody for the ultra-orphan indication of congenital hyperInsulinism; AB101-Phase 1, a once-weekly injectable basal insulin; and RZ402 which targets diabetic macular edema. The company was founded by Nevan Charles Elam, Ho Young Huh, and Sankaram Mantripragada on July 26, 2010 and is headquartered in Redwood City, CA.

ANTB Stock News Headlines

Move Your Money Before May 1
Did you know that the IRS has allegedly been using AI to spy on the bank accounts of American citizens?
Aerodrom Nikola Tesla ad AERO
Move Your Money Before May 1
Did you know that the IRS has allegedly been using AI to spy on the bank accounts of American citizens?
Remarkable Roman ruins still standing
Beautiful Roman ruins everyone should see
Staggering Roman ruins still standing
See More Headlines
Receive ANTB Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for (ANTB) and its competitors with MarketBeat's FREE daily newsletter.

Industry, Sector and Symbol

Industry
Internet Software & Services
Sub-Industry
N/A
Current Symbol
OTCMKTS:ANTB
Fax
N/A
Employees
N/A
Year Founded
N/A

Profitability

Pretax Margin
N/A

Debt

Sales & Book Value

Annual Sales
N/A

Miscellaneous

Free Float
N/A
Optionable
Not Optionable
Beta
N/A
13 Stocks Institutional Investors Won't Stop Buying Cover

Which stocks are major institutional investors including hedge funds and endowments buying in today's market? Click the link below and we'll send you MarketBeat's list of thirteen stocks that institutional investors are buying up as quickly as they can.

Get This Free Report

Key Executives

  • Nevan Charles Elam
    President, Chief Executive Officer, CFO & Director
  • Michael Deperro
    Head-Operations
  • Sankaram Mantripragada
    Chief Scientific Officer
  • Erin O’Boyle
    Head-Clinical Operations
  • Davelyn Hood
    Director-Scientific & Patient Affairs

ANTB Stock Analysis - Frequently Asked Questions

What other stocks do shareholders of (ANTB) own?
This page (OTCMKTS:ANTB) was last updated on 4/26/2024 by MarketBeat.com Staff

From Our Partners